Genmab — Juni 2018
-
Det gør jeg bestemt heller ikke. Ethvert forsøg der fejler er skidt nyt - specielt for patienterne. Jeg spørger ud fra et forståelsesmæssigt synspunkt.
-
Ja, men det er ikke det jeg spørger om.
-
Ok. Tak. Skal du have @Sukkeralf
-
Ok. Tak. Det er altså i princippet den omvendte verden i forhold til Genmab's aftale med JNJ om dara.
-
Vi håber for alle parter at der kommer nogle gode resultater i H2 eller tidligt i 2019

-
-
EMA restricts use of Keytruda and Tecentriq in bladder cancer http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/05/news_detail_002964.jsp&mid=WC0b01ac058004d5c1
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind